Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

13-Jan-19 - 11-Jan-20
Buy Ratio:38%

Up

# Net Buyers:99
# Net Sellers:159

Previous 52 Weeks

14-Jan-18 - 12-Jan-19
Buy Ratio:34%
# Net Buyers:102
# Net Sellers:201
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.--$1.27B  
Sucampo Pharmaceuticals, Inc.--$195.42M  
Usana Health Sciences Inc($5.36M)$188.04M  
Regeneron Pharmaceuticals, Inc.($135.72M)$182.87M  
Eli Lilly & Co($355.22M)$160.05M  
New Net Buyers
CompanyNet Buy AmountChange
Heron Therapeutics, Inc. /de/$5.15M$114.78M  
Amyris, Inc.$23.41M$78.68M  
Intercept Pharmaceuticals, Inc.$3.09M$76.81M  
Myriad Genetics Inc$5.29M$41.58M  
Xencor Inc$2.12M$35.25M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Corium International, Inc.--($304.33M)  
Osiris Therapeutics, Inc.($281.65M)($281.65M)  
Seattle Genetics Inc /wa($14.55M)($265.82M)  
Spark Therapeutics, Inc.($256.00M)($252.34M)  
New Net Sellers
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Seattle Genetics Inc /wa($14.55M)($265.82M)  
Kalvista Pharmaceuticals, Inc.($36.75M)($54.99M)  
Achaogen, Inc.($2.12M)($32.90M)  
Lexicon Pharmaceuticals, Inc.($264.58K)($23.46M)